Table 5.
Association between PAR-2 and clinicopathological characteristics in gastric carcinoma
| Variables | Cases (n) | PAR-2 positive rate (%) | P value |
|---|---|---|---|
| Sex | P=0.7461 | ||
| Male | 90 | 91.11 | |
| Female | 51 | 94.12 | |
| Ages | P=1.0000 | ||
| ≤60 | 58 | 93.10 | |
| >60 | 83 | 91.57 | |
| Tumor differentiation | P=0.1568 | ||
| Well/moderately differentiated | 37 | 86.48 | |
| Poorly differentiated | 104 | 94.23 | |
| TNM staging | P=0.0001 | ||
| I-II | 29 | 72.41 | |
| III-IV | 112 | 97.32 | |
| Lymph node metastasis | P=0.0122 | ||
| No | 30 | 80.00 | |
| Yes | 111 | 95.50 |
GC, gastric carcinoma. *P<0.05, statistically significant.